Top

Published in:

01-10-2021 | Tachyarrythmia

Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor’s page series

Author: Richard C. Becker

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2021

Abstract

The autonomic nervous system (ANS) is a complex network of nerves originating in the brain, brain stem, spinal cord, heart and extracardiac organs that regulates neural and physiological responses to internal and external environments and conditions. A common observation among patients with the 2019 Coronavirus (CoV) (SARS-severe acute respiratory syndrome CoV-2) (SARS-CoV-2) or COVID-19 [CO for corona, VI for virus, D for disease and 19 for when the outbreak was first identified (31 December 2019)] in the acute and chronic phases of the disease is tachycardia, labile blood pressure, muscular fatigue and shortness of breath. Because abnormalities in the ANS can contribute to each of these symptoms, herein a review of autonomic dysfunction in SARS-COV-2 infection is provided to guide diagnostic testing, patient care and research initiatives.

Graphic abstract

The autonomic nervous system is a complex network of nerves originating in the brain, brain stem, spinal cord, heart and extracardiac organs that regulates neural and physiological responses to internal and external environments and conditions. A common collection of signs and symptoms among patients with the 2019 Coronavirus (CoV) (SARS-severe acute respiratory syndrome CoV-2) (SARS-CoV-2) or COVID-19 [CO for corona, VI for virus, D for disease and 19 for when the outbreak was first identified (31 December 2019)] is tachycardia, labile blood pressure, muscular fatigue and shortness of breath. Abnormalities in the autonomic nervous system (ANS) can contribute to each of these identifiers, potentially offering a unifying pathobiology for acute, subacute and the long-term sequelae of SARS-CoV-2 infection (PASC) and a target for intervention.

Goldberger JJ et al (2019) Autonomic nervous system dysfunction: JACC focus seminar. J Am Coll Cardiol 73(10):1189–1206PubMedPubMedCentralCrossRef

Del Rio R, Marcus NJ, Inestrosa NC (2020) Potential role of autonomic dysfunction in Covid-19 morbidity and mortality. Front Physiol 11:561749PubMedPubMedCentralCrossRef

Tracey KJ (2002) The inflammatory reflex. Nature 420(6917):853–859PubMedCrossRef

Koopman FA et al (2011) Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol Med 17(9–10):937–948PubMedPubMedCentralCrossRef

Armour JA et al (1997) Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec 247(2):289–298PubMedCrossRef

Chouchou F, Desseilles M (2014) Heart rate variability: a tool to explore the sleeping brain? Front Neurosci 8:402PubMedPubMedCentralCrossRef

Guyenet PG (2006) The sympathetic control of blood pressure. Nat Rev Neurosci 7(5):335–346PubMedCrossRef

Reisert M, Weiller C, Hosp JA (2021) Displaying the autonomic processing network in humans—a global tractography approach. Neuroimage 231:117852PubMedCrossRef

Shivkumar K et al (2016) Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. J Physiol 594(14):3911–3954PubMedPubMedCentralCrossRef

10.

Isaacson SH et al (2021) Management strategies for comorbid supine hypertension in patients with neurogenic orthostatic hypotension. Curr Neurol Neurosci Rep 21(4):18PubMedPubMedCentralCrossRef

11.

Becker RC (2020) COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis 50:499–511PubMedCrossRef

12.

Robles-Cabrera A et al (2014) The cardiovagal, cardiosympathetic and vasosympathetic arterial baroreflexes and the neural control of short-term blood pressure. Rev Neurol 59(11):508–516PubMed

13.

Kirchheim HR (1976) Systemic arterial baroreceptor reflexes. Physiol Rev 56(1):100–177PubMedCrossRef

14.

Mortara A et al (1997) Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation 96(10):3450–3458PubMedCrossRef

15.

Grönloh MLB, Arts JJG, van Buul JD (2021) Neutrophil transendothelial migration hotspots - mechanisms and implications. J Cell Sci. https://doi.org/10.1242/jcs.255653CrossRefPubMed

16.

Dessalles CA, Babataheri A, Barakat AI (2021) Pericyte mechanics and mechanobiology. J Cell Sci. https://doi.org/10.1242/jcs.240226CrossRefPubMed

17.

Shepro D, Morel NML (1993) Pericyte physiology. FASEB J 7(11):1031–1038PubMedCrossRef

18.

Sims DE (2000) Diversity within pericytes. Clin Exp Pharmacol Physiol 27(10):842–846PubMedCrossRef

19.

O’Rourke MF, Safar ME (2005) Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 46(1):200–204PubMedCrossRef

20.

Proebstl D et al (2012) Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J Exp Med 209(6):1219–1234PubMedPubMedCentralCrossRef

21.

Bohannon DG, Long D, Kim WK (2021) Understanding the heterogeneity of human pericyte subsets in blood-brain barrier homeostasis and neurological diseases. Cells 10(4):890PubMedPubMedCentralCrossRef

22.

Bruns RR, Palade GE (1968) Studies on blood capillaries: I. General organization of blood capillaries in muscle. J Cell Biol 37(2):244–276PubMedPubMedCentralCrossRef

23.

Dore-Duffy P et al (2000) Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res 60(1):55–69PubMedCrossRef

24.

Litviňuková M et al (2020) Cells of the adult human heart. Nature 588(7838):466–472PubMedPubMedCentralCrossRef

25.

Muus C et al (2021) Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat Med 27(3):546–559PubMedCrossRef

26.

Behrens R et al (2021) Mini review: central organization of airway afferent nerve circuits. Neurosci Lett 744:135604PubMedCrossRef

27.

Driessen AK et al (2018) Reflex regulation of breathing by the paratrigeminal nucleus via multiple bulbar circuits. Brain Struct Funct 223(9):4005–4022PubMedCrossRef

28.

Silva ÉP et al (2021) Heart rate recovery in asthmatic children and adolescents after clinical field test. BMC Pulm Med 21(1):61PubMedPubMedCentralCrossRef

29.

Tang LYW et al (2021) Autonomic alterations after pulmonary vein isolation in the CIRCA-DOSE (cryoballoon vs irrigated radiofrequency catheter ablation) study. J Am Heart Assoc 10(5):18610CrossRef

30.

García-Lunar I et al (2020) Neurohormonal modulation as a therapeutic target in pulmonary hypertension. Cells 9(11):2521PubMedCentralCrossRef

31.

Constantine A, Dimopoulos K (2021) Pulmonary artery denervation for pulmonary arterial hypertension. Trends Cardiovasc Med 31(4):252–260PubMedCrossRef

32.

Perros F et al (2015) Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension. J Am Coll Cardiol 65(7):668–680PubMedCrossRef

33.

Tantucci C et al (2021) Respiratory function, autonomic dysfunction, and systemic inflammation are closely linked in patients with COPD and tidal flow limitation: An exploratory study. Respir Physiol Neurobiol 284:103565PubMedCrossRef

34.

Heindl S et al (2001) Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 164(4):597–601PubMedCrossRef

35.

Guardiola J, Saad M, Yu J (2019) Hypertonic saline stimulates vagal afferents that respond to lung deflation. Am J Physiol 317(6):R814–R817

36.

Koike H (2015) Acute sensory neuropathies and acute autonomic neuropathies. Brain Nerve 67(11):1377–1387PubMed

37.

Feldman EL et al (1991) Acute pandysautonomic neuropathy. Neurology 41(5):746–748PubMedCrossRef

38.

Reilly CC et al (2020) Breathlessness and dysfunctional breathing in patients with postural orthostatic tachycardia syndrome (POTS): the impact of a physiotherapy intervention. Auton Neurosci 223:102601PubMedCrossRef

39.

Tooba R et al (2021) Dyspnea in chronic low ventricular preload states. Ann Am Thorac Soc 18(4):573–581PubMedCrossRefPubMedCentral

40.

Cherneva RV, Denchev SV, Cherneva ZV (2020) The link between dynamic hyperinflation, autonomic dysfunction and exercise testing parameters with masked heart failure in patients with non-severe obstructive pulmonary disease. J Basic Clin Physiol Pharmacol 32(3):179–188PubMedCrossRef

41.

Cerri M, Amici R (2021) Thermoregulation and sleep: functional interaction and central nervous control. Compr Physiol 11(2):1591–1604PubMedCrossRef

42.

Liang J et al (2018) The independent and combined effects of respiratory events and cortical arousals on the autonomic nervous system across sleep stages. Sleep Breath 22(4):1161–1168PubMedCrossRef

43.

Monti A et al (2002) Autonomic control of the cardiovascular system during sleep in normal subjects. Eur J Appl Physiol 87(2):174–181PubMedCrossRef

44.

Kai S et al (2021) Cardiac autonomic nervous system activity during slow breathing in supine position. Rehabil Res Pract 2021:6619571PubMedPubMedCentral

45.

Kai S et al (2016) Effectiveness of moderate intensity interval training as an index of autonomic nervous activity. Rehabil Res Pract 2016:6209671PubMedPubMedCentral

46.

Delgado-Ortiz L et al (2021) Physical activity and cardiac autonomic dysfunction in patients with chronic obstructive pulmonary disease: a cross-sectional analysis. Ann Phys Rehabil Med. https://doi.org/10.1016/j.rehab.2021.101501CrossRefPubMed

47.

Stockelman KA et al (2021) Regular aerobic exercise counteracts endothelial vasomotor dysfunction associated with insufficient sleep. Am J Physiol Heart Circ Physiol 320(3):H1080-h1088PubMedCrossRefPubMedCentral

48.

Wirth KJ, Scheibenbogen C (2021) Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). J Transl Med 19(1):162PubMedPubMedCentralCrossRef

49.

Stute NL, Koopmans PJ (2021) Pushing the needle forward on the relationship between autoimmunity and autonomic dysfunction. J Physiol 599(4):1039–1040PubMedCrossRef

50.

Feldman JL, Gray PA (2000) Sighs and gasps in a dish. Nat Neurosci 3(6):531–532PubMedCrossRef

51.

Porges WL et al (2000) Heart-lung interactions: the sigh and autonomic control in the bronchial and coronary circulations. Clin Exp Pharmacol Physiol 27(12):1022–1027PubMedCrossRef

52.

Bowes G et al (1983) Carotid chemoreceptor regulation of expiratory duration. J Appl Physiol Respir Environ Exerc Physiol 54(5):1195–1201PubMed

53.

Wilhelm FH, Trabert W, Roth WT (2001) Physiologic instability in panic disorder and generalized anxiety disorder. Biol Psychiatry 49(7):596–605PubMedCrossRef

54.

Boulding R et al (2016) Dysfunctional breathing: a review of the literature and proposal for classification. Eur Respir Rev 25(141):287–294PubMedCrossRef

55.

Courtney R et al (2011) Medically unexplained dyspnea: partly moderated by dysfunctional (thoracic dominant) breathing pattern. J Asthma 48(3):259–265PubMedCrossRef

56.

Debeaumont D et al (2021) Cardiopulmonary exercise testing to assess persistent symptoms at 6 months in people with COVID-19 who survived hospitalization - a pilot study. Phys Ther 101:6. https://doi.org/10.1093/ptj/pzab099CrossRef

57.

Bajić D, Đajić V, Milovanović B (2021) Entropy analysis of COVID-19 cardiovascular signals. Entropy (Basel) 23(1):87CrossRef

58.

Zou R et al (2021) Clinical characteristics and hemodynamic responses to head-up tilt test in children and adolescents with unexplained sighing. Neurol Sci. https://doi.org/10.1007/s10072-020-04956-8CrossRefPubMedPubMedCentral

59.

Denis F et al (2021) A self-assessment web-based app to assess trends of the COVID-19 pandemic in France: observational study. J Med Internet Res 23(3):e26182PubMedPubMedCentralCrossRef

60.

Quer G et al (2021) Wearable sensor data and self-reported symptoms for COVID-19 detection. Nat Med 27(1):73–77PubMedCrossRef

61.

Zens M et al (2020) App-based tracking of self-reported COVID-19 symptoms: analysis of questionnaire data. J Med Internet Res 22(9):21956CrossRef

62.

Johansson M et al (2021) Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep 3(4):573–580PubMedPubMedCentralCrossRef

63.

Mondal R et al (2021) COVID-19 and emerging spinal cord complications: a systematic review. Mult Scler Relat Disord 51:102917PubMedPubMedCentralCrossRef

64.

Garg RK, Paliwal VK, Gupta A (2021) Spinal cord involvement in COVID-19: a review. J Spinal Cord Med. https://doi.org/10.1080/10790268.2021.1888022CrossRefPubMed

65.

Su XW et al (2020) SARS-CoV-2-associated Guillain–Barré syndrome with dysautonomia. Muscle Nerve 62(2):E48-e49PubMedCrossRef

66.

Andalib S et al (2021) Peripheral nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep 21(3):9PubMedPubMedCentralCrossRef

67.

Watari M et al (2018) Autoimmune postural orthostatic tachycardia syndrome. Ann Clin Transl Neurol 5(4):486–492PubMedPubMedCentralCrossRef

68.

Raj SR et al (2009) Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation 120(9):725–734PubMedPubMedCentralCrossRef

69.

Olshansky B, Sullivan RM (2019) Inappropriate sinus tachycardia. Europace 21(2):194–207PubMedCrossRef

70.

Baruscotti M et al (2016) Current understanding of the pathophysiological mechanisms responsible for inappropriate sinus tachycardia: role of the If “funny” current. J Interv Card Electrophysiol 46(1):19–28PubMedCrossRef

71.

Calò L et al (2010) Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm 7(9):1318–1323PubMedCrossRef

72.

Ptaszynski P et al (2013) Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy. Europace 15(1):116–121PubMedCrossRef

73.

Mathew ST, Po SS, Thadani U (2018) Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: a pooled analysis of prospective studies. Heart Rhythm 15(2):240–247PubMedCrossRef

74.

Engin AB, Engin ED, Engin A (2021) Current opinion in neurological manifestations of SARS-CoV-2 infection. Curr Opin Toxicol 25:49–56PubMedPubMedCentralCrossRef

75.

Paniz-Mondolfi A et al (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 92(7):699–702CrossRefPubMed

76.

Rodriguez M et al (2020) Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the nervous system: implications of COVID-19 in neurodegeneration. Front Neurol 11:15. https://doi.org/10.3389/fneur.2020.583459CrossRef

77.

Kanberg N et al (2020) Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology 95(12):e1754–e1759PubMedCrossRef

78.

Zhou Z et al (2020) Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol 267(8):2179–2184PubMedCrossRefPubMedCentral

79.

Becker RC (2020) COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis 50(3):499–511PubMedCrossRef

80.

Meinhardt J et al (2021) Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 24(2):168–175PubMedCrossRef

81.

Al-Dalahmah O et al (2020) Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol Commun 8(1):147PubMedPubMedCentralCrossRef

82.

Boldrini M, Canoll PD, Klein RS (2021) How COVID-19 affects the brain. JAMA Psychiatry 78:682PubMedCrossRef

83.

Blitshteyn S, Whitelaw S (2021) Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res 69:212PubMedCrossRefPubMedCentral

84.

Tagaloa E et al (2021) A rare case of Guillain-Barré syndrome with severe pandysautonomia. J Investig Med High Impact Case Rep 9:23247096211019560PubMedPubMedCentral

85.

Kaliyaperumal D et al (2021) Characterization of cardiac autonomic function in COVID-19 using heart rate variability: a hospital based preliminary observational study. J Basic Clin Physiol Pharmacol 32:247PubMedCrossRef

86.

Guaraldi P et al (2020) Testing cardiovascular autonomic function in the COVID-19 era: lessons from Bologna’s Autonomic Unit. Clin Auton Res 30(4):325–330PubMedPubMedCentralCrossRef

87.

Haensel A et al (2008) The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology 33(10):1305–1312PubMedPubMedCentralCrossRef

88.

Haarala A et al (2011) Heart rate variability is independently associated with C-reactive protein but not with Serum amyloid A. The cardiovascular risk in young finns study. Eur J Clin Invest 41(9):951–957PubMedCrossRef

89.

Martínez-Rosales E et al (2020) Heart rate variability in women with systemic lupus erythematosus: association with health-related parameters and effects of aerobic exercise. Int J Environ Res Public Health 17(24):9501PubMedCentralCrossRef

90.

Baptista AF et al (2020) Applications of non-invasive neuromodulation for the management of disorders related to COVID-19. Front Neurol 11:573718PubMedPubMedCentralCrossRef

91.

Moroi MK et al (2021) Prevention and management of supine hypertension in patients with orthostatic hypotension. Am J Ther 28(2):e228–e231PubMedCrossRef

92.

Kario K et al (2021) Effect of the nonsteroidal mineralocorticoid receptor blocker, esaxerenone, on nocturnal hypertension: a post hoc analysis of the ESAX-HTN study. Am J Hypertens 34(5):540–551PubMedCrossRef

93.

Okamoto LE et al (2021) Local passive heat for the treatment of hypertension in autonomic failure. J Am Heart Assoc 10(7):18979CrossRef

94.

Shannon J et al (1997) The hypertension of autonomic failure and its treatment. Hypertension 30(5):1062–1067PubMedCrossRef

95.

Lo A et al (2021) Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension. Clin Auton Res 31:395–403PubMedPubMedCentralCrossRef

96.

Nikolin S et al (2019) Comparison of site localization techniques for brain stimulation. J ECT 35(2):127–132PubMedCrossRef

97.

Okano AH et al (2015) Brain stimulation modulates the autonomic nervous system, rating of perceived exertion and performance during maximal exercise. Br J Sports Med 49(18):1213–1218PubMedCrossRef

Title: Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor’s page series
Author: Richard C. Becker
Publication date: 01-10-2021
Publisher: Springer US
Keywords: Tachyarrythmia
SARS-CoV-2
COVID-19
Published in: Journal of Thrombosis and Thrombolysis / Issue 3/2021
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-021-02549-6

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Graphic abstract

Please log in to get access to this content

Other articles of this Issue 3/2021

Outcomes of a multi-ethnic Asian population on combined treatment with clopidogrel and omeprazole in 12,440 patients

Stroke and presence of patent foramen ovale in sickle cell disease

Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE)

Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis

Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis

Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage